Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
| Actual shortage: | 249 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-07-14 | 2021-05-06 | 120306 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Resolved | 2020-07-14 | 2021-05-06 | 120303 |
| CARBOPLATIN INJECTION | 10MG | LIQUID | Actual shortage | 2021-03-04 | 2021-04-29 | 135135 |
| TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-03-25 | 2021-04-29 | 136332 |
| TEVA-TOLTERODINE LA | 2MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-03-18 | 2021-04-29 | 135952 |
| NV-CLINDAMYCIN | 150MG | CAPSULE | Resolved | 2021-03-11 | 2021-04-29 | 135561 |
| TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-02-11 | 2021-04-29 | 133770 |
| CISPLATIN INJECTION | 1.0MG | SOLUTION | Resolved | 2021-02-05 | 2021-04-29 | 133457 |
| TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2021-01-28 | 2021-04-29 | 132660 |
| TEVA-CILAZAPRIL/HCTZ | 5MG 12.5MG | TABLET | Resolved | 2020-10-22 | 2021-04-29 | 126948 |
| TEVA-FLUVASTATIN | 20MG | CAPSULE | Resolved | 2020-10-01 | 2021-04-29 | 125491 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-06-25 | 2021-04-29 | 118960 |
| TEVA-VALSARTAN | 320MG | TABLET | Actual shortage | 2021-04-22 | 2021-04-22 | 137939 |
| TEVA-VALSARTAN | 40MG | TABLET | Actual shortage | 2021-04-22 | 2021-04-22 | 137930 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Actual shortage | 2019-09-26 | 2021-04-22 | 94834 |
| TEVA-SERTRALINE | 50MG | CAPSULE | Resolved | 2021-04-15 | 2021-04-21 | 137547 |
| TEVA-QUETIAPINE XR | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-03-25 | 2021-04-21 | 136341 |
| TEVA-TRAZODONE | 150MG | TABLET | Resolved | 2021-03-25 | 2021-04-21 | 136335 |
| TEVA-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-03-18 | 2021-04-21 | 135980 |
| TEVA-QUETIAPINE XR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-03-18 | 2021-04-21 | 135977 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
| GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
| CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
| CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
| CLOXACILLIN SODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14014 |
| TEVA-PRAMIPEXOLE | 1.5MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14007 |